Home › NDC Lookup › RxCUI directory › RxCUI 2669721

0.5 ML tirzepatide 30 MG/ML Auto-Injector [Zepbound] — RxCUI 2669721

RxNorm drug concept · Semantic branded drug
RxCUI 2669721 Semantic branded drug · SBD ● Current RxNorm concept 24 FDA products 33 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2669721
Official name0.5 ML tirzepatide 30 MG/ML Auto-Injector [Zepbound]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as0.5 ML Zepbound 30 MG/ML Auto-Injector; zepbound 15 MG in 0.5 ML Auto-Injector; Zepbound 15 MG per 0.5 ML Auto-Injector
FDA products mapped24
Package NDCs mapped33
Reported Medicaid activity (SDUD)1,688,466 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tirzepatide injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's actually both, depending on which brand you have. Mounjaro is FDA-approved to help control blood sugar in people with type 2 diabetes. Zepbound is approved for weight manageme...
  • What exactly is tirzepatide used for — is it a diabetes drug or a weight-loss drug?
  • Nausea, diarrhea, and vomiting are the most common side effects, especially in the first few weeks or after a dose increase. The good news is that they tend to improve as your body...
  • Will I feel sick to my stomach when I start taking it?
📖 Read our full Tirzepatide injection guide →

🕸️ Concept Web — How 0.5 ML tirzepatide 30 MG/ML Auto-Injector [Zepbo... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.5 ML tirzepatide 30 MG/ML Auto-Injector [Zepbound] RxCUI 2669721

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tirzepatide 2601723
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zepbound 2669702
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tirzepatide Auto-Injector 2601731
    • Tirzepatide Injectable Product 2601730
    • Tirzepatide Auto-Injector [Zepbound] 2669705
    • Zepbound Injectable Product 2669704
    • Auto-Injector 1649570
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Tirzepatide 30 MG/ML [Zepbound] SBDC · 2669720
  • Tirzepatide Auto-Injector [Zepbound] SBDF · 2669705
  • Zepbound Injectable Product SBDG · 2669704
  • Zepbound BN · 2669702

📦 FDA Products & Package NDCs

24 products · 33 package NDCs
33 package NDCs map to RxCUI 2669721 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00002-0152-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-0152-01) / .5 mL in 1... Zepbound Eli Lilly and Company 2024-03-28
00002-0152-04 4 VIAL, SINGLE-DOSE in 1 CARTON (0002-0152-04) / .5 mL in 1... Zepbound Eli Lilly and Company 2024-08-08
00002-0152-61 4 VIAL, SINGLE-DOSE in 1 CARTON (0002-0152-61) / .5 mL in 1... Zepbound Eli Lilly and Company 2025-05-01
00002-0243-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-0243-01) / .5 mL in 1... Zepbound Eli Lilly and Company 2024-03-28
00002-0243-04 4 VIAL, SINGLE-DOSE in 1 CARTON (0002-0243-04) / .5 mL in 1... Zepbound Eli Lilly and Company 2024-08-08
00002-1214-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-1214-01) / .5 mL in 1... Zepbound Eli Lilly and Company 2024-03-28
00002-1214-04 4 VIAL, SINGLE-DOSE in 1 CARTON (0002-1214-04) / .5 mL in 1... Zepbound Eli Lilly and Company 2025-02-18
00002-1340-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-1340-01) / .5 mL in 1... Zepbound Eli Lilly and Company 2024-03-28
00002-1340-04 4 VIAL, SINGLE-DOSE in 1 CARTON (0002-1340-04) / .5 mL in 1... Zepbound Eli Lilly and Company 2025-02-18
00002-1423-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-1423-01) / .5 mL in 1... Zepbound Eli Lilly and Company 2024-03-28
00002-1423-04 4 VIAL, SINGLE-DOSE in 1 CARTON (0002-1423-04) / .5 mL in 1... Zepbound Eli Lilly and Company 2025-07-07
00002-2002-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-2002-01) / .5 mL in 1... Zepbound Eli Lilly and Company 2024-03-28
00002-2002-04 4 VIAL, SINGLE-DOSE in 1 CARTON (0002-2002-04) / .5 mL in 1... Zepbound Eli Lilly and Company 2025-07-07
00002-2457-80 4 SYRINGE in 1 CARTON (0002-2457-80) / .5 mL in 1 SYRINGE (... ZEPBOUND Eli Lilly and Company 2023-11-08
00002-2460-80 4 SYRINGE in 1 CARTON (0002-2460-80) / .5 mL in 1 SYRINGE (... ZEPBOUND Eli Lilly and Company 2023-11-08
00002-2471-80 4 SYRINGE in 1 CARTON (0002-2471-80) / .5 mL in 1 SYRINGE (... ZEPBOUND Eli Lilly and Company 2023-11-08
00002-2484-80 4 SYRINGE in 1 CARTON (0002-2484-80) / .5 mL in 1 SYRINGE (... ZEPBOUND Eli Lilly and Company 2023-11-08
00002-2495-80 4 SYRINGE in 1 CARTON (0002-2495-80) / .5 mL in 1 SYRINGE (... ZEPBOUND Eli Lilly and Company 2023-11-08
00002-2506-61 4 SYRINGE in 1 CARTON (0002-2506-61) / .5 mL in 1 SYRINGE ZEPBOUND Eli Lilly and Company 2023-11-08
00002-2506-80 4 SYRINGE in 1 CARTON (0002-2506-80) / .5 mL in 1 SYRINGE (... ZEPBOUND Eli Lilly and Company 2023-11-08
00002-3511-11 1 SYRINGE in 1 CARTON (0002-3511-11) / 2.4 mL in 1 SYRINGE... Zepbound KwikPen Eli Lilly and Company 2026-01-20
00002-3522-11 1 SYRINGE in 1 CARTON (0002-3522-11) / 2.4 mL in 1 SYRINGE... Zepbound KwikPen Eli Lilly and Company 2026-01-20
00002-3533-11 1 SYRINGE in 1 CARTON (0002-3533-11) / 2.4 mL in 1 SYRINGE... Zepbound KwikPen Eli Lilly and Company 2026-01-20
00002-3544-11 1 SYRINGE in 1 CARTON (0002-3544-11) / 2.4 mL in 1 SYRINGE... Zepbound KwikPen Eli Lilly and Company 2026-01-20
00002-3555-11 1 SYRINGE in 1 CARTON (0002-3555-11) / 2.4 mL in 1 SYRINGE... Zepbound KwikPen Eli Lilly and Company 2026-01-20
00002-3566-11 1 SYRINGE in 1 CARTON (0002-3566-11) / 2.4 mL in 1 SYRINGE... Zepbound KwikPen Eli Lilly and Company 2026-01-20
00002-3566-99 1 SYRINGE in 1 CARTON (0002-3566-99) / 2.4 mL in 1 SYRINGE Zepbound KwikPen Eli Lilly and Company 2026-03-01
00002-6052-11 1 VIAL, MULTI-DOSE in 1 CARTON (0002-6052-11) / 2.4 mL in 1... Zepbound Eli Lilly and Company 2026-01-07
00002-6103-11 1 VIAL, MULTI-DOSE in 1 CARTON (0002-6103-11) / 2.4 mL in 1... Zepbound Eli Lilly and Company 2026-01-07
00002-6210-11 1 VIAL, MULTI-DOSE in 1 CARTON (0002-6210-11) / 2.4 mL in 1... Zepbound Eli Lilly and Company 2026-01-07
00002-6304-11 1 VIAL, MULTI-DOSE in 1 CARTON (0002-6304-11) / 2.4 mL in 1... Zepbound Eli Lilly and Company 2026-01-07
00002-6523-11 1 VIAL, MULTI-DOSE in 1 CARTON (0002-6523-11) / 2.4 mL in 1... Zepbound Eli Lilly and Company 2026-01-07
00002-6612-11 1 VIAL, MULTI-DOSE in 1 CARTON (0002-6612-11) / 2.4 mL in 1... Zepbound Eli Lilly and Company 2026-01-07
Observed labelers: Eli Lilly and Company (33) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.